Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix

1. Scott M. The pathology of cervical cancer. In: Ayhan A, Reed N, Gulterin M, Dursun P, editors. Textbook of Gynaecological Oncology. 3rd ed. Ankara, Turkey: Gunes Publishing; 2016. pp. 376-380.Search in Google Scholar

2. American College of Obstetricians and Gynaecologists. ACOG Practice Bulletin No99: Management of abnormal cervical cytology and histology. Obstet Gynecol 2008; 112(6); 1419-1444. Reaffirmed 2010.10.1097/AOG.0b013e318192497c19037054Search in Google Scholar

3. Martin CM, O’Leary JJ. Histology of cervical intraepithelial neoplasia and the role of biomarkers. In: Arul Kumaran S, editor. Best Practice & Research: Clinical Obstetrics & Gynaecology. 25th ed. Philadelphia, USA: Elsevier; 2011. pp. 605-615.10.1016/j.bpobgyn.2011.04.00521636328Search in Google Scholar

4. Abreu ALP, Souza RP, Gimenes F, et al. A review of methods for detect human papillomavirus infection. Virology Journal 2012; 9:262.10.1186/1743-422X-9-262350785223131123Open DOISearch in Google Scholar

5. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. 2008; 26:29-41.10.1016/j.vaccine.2008.06.019Search in Google Scholar

6. Rosenblatt S, Wroclawski ER, Lucon AM, Pereyra EAG, editors. HPV in Clinical Practice. Sao Paulo: Atheneu; 2005.Search in Google Scholar

7. Hwang SJ, Shroyer KR. Biomarkers of Cervical Dysplasia and Carcinoma. Journal of Oncology 2012; 2012:9.10.1155/2012/507286320568722131995Open DOISearch in Google Scholar

8. Coquillard G, Palao B, Patterson BK. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol 2011; 120(1):89-93.10.1016/j.ygyno.2010.09.01320950847Search in Google Scholar

9. Sorbye SW, Arbyn M, Fismen S, et al. HPV E6/ E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy. PLoS ONE 2011; 6(10):e26022.10.1371/journal.pone.0026022318858221998748Search in Google Scholar

10. Kraus I, Molden T, Holm R, et al. Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33 and 45 in the Majority of Cervical Carcinomas. J Clin Microbiol 2006; 44:1310–1317.10.1128/JCM.44.4.1310-1317.2006144867416597856Search in Google Scholar

11. Zerat L. La nouvelle terminologie de Bethesda: quellschangements? Rev Prat Gynecol Obstet. Numero Special 2002; 3-10.Search in Google Scholar

12. Solomon D, Davey D, Kurman R. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-19.10.1001/jama.287.16.211411966386Search in Google Scholar

13. Kurman RJ, Carcangin ML, Herrington CS, Young RH, editors. World Health Organization Classification of Tumors of Female Reproductive Organs. 4th ed. Lyon, France: IARC Press; 2014.Search in Google Scholar

14. Castle PE, Dockter J, Giachetti G, et al. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. AACR 2007; 13:2599-2605.10.1158/1078-0432.CCR-06-288117473189Search in Google Scholar

15. Vieira L, Almeida A. The cytology and DNA detection by the Papillo Check test in the diagnosis of human papillomavirus infection. Eur J Microbiol Immunol 2013; 3(1):61-7.10.1556/EuJMI.3.2013.1.9383207924265920Search in Google Scholar

16. Mazarico E, Gonzalez-Bosquet E. Prevalence of infection by different genotypes of human papillomavirus in women with cervical pathology. Gynecol Oncol 2012; 125(1):181-5.10.1016/j.ygyno.2011.12.45022226808Search in Google Scholar

17. Pista A, de Oliveira CF, Lopes C, et al; CLEOPATRE Portugal Study Group. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study. Int J Gynecol Cancer 2013; 23(3):500-6.10.1097/IGC.0b013e318280f26e23392401Open DOISearch in Google Scholar

18. Bzhalava D, Eklund C, Dillner J. International standardization and classification of human papillomavirus types. Virology. 2015; 476:341-4.10.1016/j.virol.2014.12.02825577151Search in Google Scholar

19. Fontecha N, Basaras M, Hernaez S, et al. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. BMC Cancer 2016; 16:852.10.1186/s12885-016-2885-x509785027816058Open DOISearch in Google Scholar

20. Oliveira A, Verdasca N, Pista A. Use of the Nucli SENS Easy Q HPV assay in the management of cervical intraepithelial neoplasia. J Med Virol 2013; 85(7):1235-1241.10.1002/jmv.2359023918542Search in Google Scholar

21. Cattani P, Siddu A, DÓnghia S, et al. RNA (E6 and E7) assay versus DNA (E6 and E7) assay for risk evaluation for women infected with human papillomavirus. J Clin Microbiol 2009; 2136-2141.10.1128/JCM.01733-08270847519403762Open DOISearch in Google Scholar

22. Tuney I, Altay A, Ergunay K, et al. HPV types and E6/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey. Turk J Med Sci 2017; 1508-155.10.3906/sag-1508-15528263489Search in Google Scholar

23. Doganov A, Kostova P, Boyanova M, et al. Application of the RNA-based HPV test in the diagnostics of cervical epithelial changes. Akush Ginekol 2012; 51(3):22-4.Search in Google Scholar

24. Trope A, Sjoborg K, Eskild A, et al. Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 2009; 47(8):2458-2464.10.1128/JCM.01863-08272563919535524Search in Google Scholar

25. Spathis A, Kottaridi C, Chranioti A, et al. mRNA and DNA detection of human papillomaviruses in women of all ages attending two colposcopy clinics. PLoS One 2012; 7(11):e49205.10.1371/journal.pone.0049205349955523166611Search in Google Scholar

26. Salimovic-Besic I, Tomic-Cica A, Smailjic A, et al. Comparison of the detection of HPV-16, 18, 31, 33 and 45 by type-specific DNA- and E6/ E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears. J virol Methods 2013; 194(1-2):222-228.10.1016/j.jviromet.2013.08.03624036071Search in Google Scholar

27. Duvlis S, Popovska-Jankovic K, Sarafimovska- Arsova Z, et al. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women. J Med Virol 2015; 87(9):1578-1586.10.1002/jmv.2419925880030Search in Google Scholar

28. Munkhdelger J, Choi Y, Lee D, et al. Comparison of the performance of the Nucli SENS Easy Q HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix. Diagnos Microbiol Inf Dis 2014; 422-427.10.1016/j.diagmicrobio.2014.04.00424856365Open DOISearch in Google Scholar